Do you want to read an article? Please log in or register.
Clinical Factors Related to Loculation of Fluid in Central Serous Chorioretinopathy
Retinal DiseasesFurther Publications
Related content
Retinal Diseases
GENETIC RISK FACTORS IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY
Retina.
Mohabati D, Schellevis RL, van Dijk EHC, Altay L, Fauser S, Hoyng CB, De Jong EK, Boon CJF, Yzer S
doi: 10.1097/IAE.
COMMENTED
Retinal Diseases
An international collaborative evaluation of central serous chorioretinopathy: different therapeutic approaches and review of literature. The European Vitreoretinal Society central serous chorioretinopathy study
★ 1
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
doi: 10.1111/aos.14319.
COMMENTED
Retinal Diseases
Eplerenone for the treatment of chronic central serous chorioretinopathy: 3-year clinical experience
Br J Ophthalmol.
Petkovsek DS, Cherfan DG, Conti FF, Hom GL, Ehlers JP, Babiuch AS, Rachitskaya AV, Kaiser PK, Schachat AP, Srivastava SK, Sharma S, Singh RP
doi: 10.1136/bjophthalmol-2019-314047.
COMMENTED
Role of the Complement System in Chronic Central Serous Chorioretinopathy: A Genome-Wide Association Study
JAMA Ophthalmol.
Schellevis RL, van Dijk EHC, Breukink MB, Altay L, Bakker B, Koeleman BPC, Kiemeney LA, Swinkels DW, Keunen JEE, Fauser S, Hoyng CB, den Hollander AI, Boon CJF, de Jong EK
doi: 10.1001/jamaophthalmol.
Retinal Diseases
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE Trial
Ophthalmology.
van Dijk EHC, Fauser S, Breukink MB, Blanco-Garavito R, Groenewoud JMM, Keunen JEE, Peters PJH, Dijkman G, Souied EH, MacLaren RE, Querques G, Downes SM, Hoyng CB, Boon CJF
doi: 10.1016/j.ophtha.
Retinal Diseases
Routine Clinical Practice Treatment Outcomes of Eplerenone in Acute and Chronic Central Serous Chorioretinopathy
Front Pharmacol
Fasler K, Gunzinger JM, Barthelmes D, Zweifel SA
doi: 10.3389/fphar.2021.675295
Association of a Haplotype in the NR3C2 Gene, Encoding the Mineralocorticoid Receptor, With Chronic Central Serous Chorioretinopathy
JAMA Ophthalmol.
van Dijk EH, Schellevis RL, van Bergen MG, Breukink MB, Altay L, Scholz P, Fauser S, Meijer OC, Hoyng CB, den Hollander AI, Boon CJ, de Jong EK
doi: 10.1001/
COMMENTED
Retinal Diseases
The Effect of Selective Retina Therapy with Automatic Real-Time Feedback-Controlled Dosimetry for Chronic Central Serous Chorioretinopathy: A Randomized, Open-Label, Controlled Clinical Trial
★ 1
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
J Clin Med
Lee JY, Kim MH, Jeon SH, Lee SH, Roh YJ
doi: 10.3390/jcm10194295
Macular DiseasesRetinal DiseasesFurther Publications
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial
JAMA Ophthalmol
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL, Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group.
doi: 10.1001/jamaophthalmol.2021.4395